Timing of norepinephrine in septic patients: NOT too little too late by Jean-Sebastien Rachoin & Richard P Dellinger
Rachoin and Dellinger Critical Care 2014, 18:691
http://ccforum.com/content/18/6/691COMMENTARYTiming of norepinephrine in septic patients: NOT
too little too late
Jean-Sebastien Rachoin1,2 and Richard P Dellinger1,3,4*
See related research by Bai et al., http://ccforum.com/content/18/5/532Abstract
After years and years of consensus expert opinion as to
mean arterial pressure (MAP) target and vasopressor
choice in septic shock management, literature is now
emerging that supports the MAP target of 65 mm Hg
and norepinephrine as the vasopressor choice. However,
the literature remains sparse as to the timing of
vasopressors relative to fluid resuscitation and how MAP
support is balanced between the choices of vasopressor
versus fluid resuscitation. Bai and colleagues report data
that reveal an association between earlier vasopressor
initiation in septic shock and better outcome. Whether
this is a linkage to better care, is related to improved
early tissue perfusion, or relates to sparing of fluids to
reach the MAP target is not yet known.These findings strengthen the mantra of early initiationIntroduction
In a previous issue of Critical Care, Bai and colleagues [1]
report the result of a retrospective study of 213 patients
with sepsis treated with norepinephrine and analyzed the
relationship of the mortality outcome to the timing of ini-
tiation of vasopressor. The authors found that patients
who had norepinephrine initiated earlier had higher mean
arterial pressure (MAP) values, lower lactic acid levels,
and lower mortality. This study supports the importance
of the role of vasopressors in achieving the MAP target in
the early resuscitation of septic shock.
Initial resuscitation of septic shock
Sepsis is a disease of common occurrence with vexingly
high mortality rates despite all of the advances in diag-
nosis, process changes, and treatment modalities [2,3].* Correspondence: dellinger-phil@cooperhealth.edu
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Campaign, if a patient with sepsis is hypotensive within
the first 6 hours of diagnosis, the clinician should initiate
vasopressor agents to raise the MAP to 65 mm Hg if
fluid resuscitation of 30 mL/kg fails to achieve that goal.
Not addressed in this study are the optimal choice for
vasopressor agent and the optimal target MAP. Other
recent studies do address these issues [4-6].
Timing of initiation of pressor therapy
Bai and colleagues performed a retrospective study of tim-
ing of initiation of norepinephrine for treatment of septic
shock. They analyzed outcomes of 213 patients admitted
to one of two intensive care units. The authors found a
strong relationship between delayed initial norepinephrine
administration and 28-day mortality.
of protocolized management of septic shock that includes
vasopressor therapy for the early achievement of an MAP
target. Perhaps this target should join early diagnosis, early
antibiotics, early and appropriate fluid resuscitation, and
source control as the essentials of septic shock manage-
ment [7].
In our mind, there are three potential reasons why earl-
ier initiation of vasopressor therapy is linked to improved
outcome. Each one deserves attention as a potential link.
Other potential reasons may yet be brought forward.
1. Earlier initiation of vasopressor therapy raises the
MAP to a level that facilitates tissue perfusion and
prevents onset or progression of organ dysfunction.
It is well recognized that organs require a critical
MAP to maintain adequate perfusion. When the
MAP is allowed to stay below that organ’s critical
perfusion pressure, organ injury may occur.
2. Earlier initiation of vasopressor therapy is linked to
better knowledge and better management skills for
severe sepsis by the treating providers. It may be
that earlier vasopressor therapy is a marker ofd Central Ltd. The licensee has exclusive rights to distribute this article, in any
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ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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improved outcomes regardless of the impact of the
vasopressor alone on outcome.
3. Earlier administration of vasopressor therapy leads
to a decrease in the amount of fluids administered
over the first 24 hours or more of therapy of septic
shock. There is concern that the use of aggressive
early fluid resuscitation in septic shock (regardless of
whether it is essential for stabilization) leads to
potential detrimental increased tissue edema down
the road in the patient with septic shock, although
this concern is not currently supported by solid
evidence. It may be that this edema is associated
with organ dysfunction, need for organ support, and
the ability to wean organ support. This could lead to
longer days on mechanical ventilation, longer days
in the intensive care unit, and the potential for
later-stage increases in morbidity and mortality. It is
possible that aggressive fluid resuscitation saves lives
on the front end but a price is paid on the back end.
There likely is a fine balance between the use of
vasopressors to maintain MAP versus the use of
continued fluid resuscitation in the presence of
capillary leak to maintain MAP. Much additional
research will be required to offer guidance to the
treating clinician. In the meantime, one should not
err on the side of fluid restriction for the sole
purpose of decreasing third spacing down the road.
Patients typically autodiurese this fluid when septic
shock has resolved and the patient is improving.
Whether facilitating this fluid exit with diuretic
therapy would be beneficial is currently unknown.Conclusions
This trial raises some important questions that need to
be answered with large prospective randomized studies:
is there an optimal time for initiation of intravenous
pressors, and are some of the components of a sepsis
protocol more important than others?Abbreviation
MAP: mean arterial pressure.Competing interests
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